Longeveron Inc.
NASDAQ: LGVN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stephen H. Willard
- Employees
- 25
- Headquarters
- Miami, United States
- IPO year
- 2021
- Market cap
- $14.8M
- Website
- https://www.longeveron.com
Loading LGVN…
Loading profile data…Frequently asked questions about LGVN
What does Longeveron Inc. (LGVN) do?
Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses. The company's primary investigational product is LOMECEL-B, a sophisticated cellular therapy....
Where does LGVN trade?
Longeveron Inc. (LGVN) trades on the NASDAQ Capital Market.
What sector is LGVN in?
Longeveron Inc. (LGVN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Longeveron Inc.?
Stephen H. Willard is the chief executive officer of Longeveron Inc. (LGVN).
Where is Longeveron Inc. headquartered?
Longeveron Inc. is headquartered in United States.
Does LGVN pay a dividend?
Longeveron Inc. (LGVN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LGVN go public?
Longeveron Inc. (LGVN) completed its initial public offering in 2021.